Skip to content

Efficacy and safety of local budesonide for pouchitis

Efficacy and safety of local budesonide for pouchitis - Efficacy of budesonide for pouchitis

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000031016
Enrollment
30
Registered
2018-02-15
Start date
2018-02-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis pouchitis

Interventions

None listed

Sponsors

Hyogo College of Medicine Department of Inflammatory Bowel Disease
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with diagnosisi of pouchitis by using modified pouchitis disease activity index.

Exclusion criteria

Exclusion criteria: under 20 years old or over 70 years old. Patients without agreement. Patients who are treated with another concomitant immunosupressive treatments.

Design outcomes

Primary

MeasureTime frame
Improving rate of pouchitis after treatment with local budesonide.

Secondary

MeasureTime frame
Safety

Countries

Japan

Contacts

Public ContactMotoi Uchino

Hyogo College of Medicine Department of Inflammatory Bowel Disease

uchino2s@hyo-med.ac.jp0798-45-6371

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026